BSc (Health Sciences), PhD
Advanced Research Fellow
- About
-
- Email Address
- r.e.thomas@abdn.ac.uk
- Telephone Number
- +44 (0)1224 438172
- Office Address
Centre for Healthcare Randomised Trials (CHaRT) Health Services Research Unit University of Aberdeen 3rd Floor, Health Sciences Building Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
I am currently a Research Manager for the Centre Healthcare Randomised Trials (CHaRT), a fully registered UK Clinical Research Collaboration Clinical Trials Unit with an internationally recognised expertise in the design, conduct, analysis and reporting of multicentre trials. I joined the Unit in 1993. I completed my PhD in the Unit in 2002 and went on to take up a Wellcome Trust Training Fellowship in Health Services Research which I completed in 2006. I am a Health Services Researcher experienced in a range of HSR methods including systematic reviews, pragmatic RCTs (simple and complex), and other evaluative designs. I have previously worked on a series of "knowledge translation" evaluations ie getting evidence into clinical practice, involving complex rigorous designs.
- Research
-
Current Research
Ongoing research
- Centre for Healthcare Randomised Trials (CHaRT)
- Therapeutic Interventions for Stones of the Ureter (TISU)
- The clinical and cost effectiveness of surgical interventions for stones in the lower calyx of the kidney: The PUrE RCT- Percutaneous Nephrolithotomy (PNL), Flexible Ureterorenoscopy (FURS) and Extracorporeal Lithotripsy (ESWL) for lower pole Calyceal Kidney Stones (PUrE)
- Multiple Symptoms Study 3: pragmatic trial of a community based clinic for patients with persistent (medically unexplained) physical symptoms.
Previous research
- Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of calcium channel blockers (nifedipine) and alpha blockers (tamsulosin) - (SUSPEND)
- The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer
- Diagnostic request advisory model: the rationalisation of laboratory test ordering in general practice (DRAM)
- Establishing a scientific rationale for choosing interventions to translate research findings into clinical practice: The PR1ME project
- The accuracy of accredited glaucoma optometrists in the diagnosis and treatment recommendation for glaucoma
- A systematic review of the effectiveness and efficiency of guideline dissemination and implementation strategies
- Cochrane Effective Practice and Organisation of Care (EPOC) Review Group
Funding and Grants
NIHR HS&DR 15/136/07 Multiple Symptoms Study 3: pragmatic trial of a community based clinic for patients with persistent (medically unexplained) physical symptoms. Start date: 1st February 2018 (42 months) Value: £1,193,035
NIHR HTA (13/152/02) The clinical and cost effectiveness of surgical interventions for stones in the lower pole calyces of the kidney: the PUrE RCT - Percutaneous Nephrolithotomy (PNL), Flexible Ureterorenoscopy (FURS) and Extracorporeal Shockwave Lithotripsy (ESWL) for lower pole calyceal kidney stones. Start date: 1st December 2015. (60 months). Value: £1,877,148.56.
Chief Scientists Office of the Scottish Government CZH/4/945 – Multiple Symptoms Study 2. A feasibility study to manualise, teach and demonstrate the delivery of the Symptoms Clinic intervention Start date: April 2014 (12 months). Value: £139,962.
NIHR HTA (10/137/01). Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. Start date: 1st March 2013 (48 months). Value: £1,426,755.
NIHR HTA (08/71/01) SUSPEND: Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multi centre placebo randomised trial. Start date: 1st June 2010 (42 months extended to 53 months). Value: £1,585,180 (+ 132,732).
NIHR HTA (07/47/01). The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer. Start date: 1st June 2008. Value: £239,474.
- Publications
-
Page 5 of 5 Results 41 to 46 of 46
Changing provider behaviour: an overview of systematic reviews of interventions to promote implementation of research findings by healthcare professionals
Getting Research Findings into Practice. Haines, A., Donald, A. (eds.). 2nd edition. BMJ Publishing, pp. 29-67, 38 pagesChapters in Books, Reports and Conference Proceedings: Chapters- [ONLINE] DOI: https://doi.org/10.1002/9780470755891.ch4
Changing provider behavior: an overview of systematic reviews of interventions
Medical Care, vol. 39, no. 8 Suppl 2, pp. 2-45Contributions to Journals: ArticlesDirect disclosure of bone density results to patients: Effect on knowledge of osteoporosis risk and anxiety level
Osteoporosis International, vol. 8, pp. 584-590Contributions to Journals: ArticlesMothers and daughters menopausal ages: Is there a link?
European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 74, no. 1, pp. 63-66Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0301-2115(97)00085-7
- [ONLINE] View publication in Scopus
Prediction of perimenopausal fractures by bone mineral density and other risk factors
Journal of Bone and Mineral Research, vol. 11, no. 2, pp. 293-297Contributions to Journals: Articles- [ONLINE] View publication in Scopus
Bone density and milk. Low recruitment rate may introduce selection bias [4]
British Medical Journal, vol. 308, no. 6943, pp. 1566Contributions to Journals: Letters- [ONLINE] View publication in Scopus